Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes
Chemotherapy and radiotherapy increased the risk of COVID-19 in cancer patients, with treatment interruptions not affecting efficacy or toxicity, underscoring the need for tailored management.
Authors
- Haoyu Liu (ORCID: https://orcid.org/0000-0001-9566-7964)
- Hui Zhu (ORCID: https://orcid.org/0000-0001-9422-3886)
- Feihu Chen (ORCID: https://orcid.org/0000-0001-6778-8363)
- Shuangqing Lu
- Hanjing Yin
- Xuquan Jing
- Min Wang (ORCID: https://orcid.org/0000-0002-1288-016X)
- Dongmei Sun (ORCID: https://orcid.org/0000-0001-7066-9541)
- Jiling Niu
Institutions
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s12879-025-11172-2
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wu Jieping Medical Foundation